UltiMaker to support Bioactivx in scale-up of 3D printing-enabled synthetic skin substitute
UltiMaker has signed a Memorandum of Understanding (MOU) with Singapore-based MedTech startup Bioactivx to co-develop a scalable, on-demand medical printing solution for regenerative wound care. The partnership follows the opening of Bioactivx's medical-grade filament production and cleanroom print farm facility and its obtainment of HSA approval for its flagship Bioactiv Matrix product. Bioactiv Matrix is a 3D…
Summary. This story was aggregated by AM News from TCT Magazine. All rights to the original content remain with the publisher.
Read the full article at TCT Magazine →
